← Leaderboards
Marcia I. Dawson
Molecular Medicine Research Institute
$4,173,024
Attributed
$4,173,024
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $529.6K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$4,693,307 · 4
By mechanism
R01$3,660,584 · 2
P01$1,032,723 · 2
Top collaborators
No co-investigators on record.
Most similar at Molecular Medicine Research Institute
Same institution · by research overlap
- Joseph A Fontana$2,820,744
- Mark E Leid$3,287,794
- Colette J Rudd$512,440
- Xiao-Kun Zhang$10,104,205
Others in their field
Top investigators on “Retinoids”
- Krzysztof Palczewski · University Of California-Irvine$33,394,447
- John E Connett · University Of Minnesota Twin Cities$20,977,187
- Lorraine J Gudas · Sloan-Kettering Institute For Cancer Res$18,380,817
- Joseph L Napoli · University Of California Berkeley$14,913,548
- William S Blaner · Columbia University Health Sciences$13,070,813
- Garrett M Brodeur · Children'S Hospital Of Philadelphia$12,100,423
Research focus
RetinoidsPharmaceutical PreparationsComputer AnalysisLigand Binding DomainMalignant NeoplasmsCancer CellElementsLigandsIn VitroLigand BindingBaseOvaryAndrogensAdverse EffectsPharmacophoreCell LineDesignComputer StudiesBreast Cancer CellInterdisciplinary ApproachBinding (Molecular Function)In VivoProteinsScaffold
Grant awards (12)
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer$392,486
R01 · FY2014 · CA · contact PI
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer$380,348
R01 · FY2013 · CA · contact PI
LRH-1 Antagonism: Impact on Estrogen-dependent Breast Cancer$404,625
R01 · FY2012 · CA · contact PI
Rexinoid Synergy in Prostate Cancer Apoptosis$529,569
R01 · FY2009 · CA · contact PI
Rexinoid Synergy in Prostate Cancer Apoptosis$510,361
R01 · FY2008 · CA · contact PI
Rexinoid Synergy in Prostate Cancer Apoptosis$491,829
R01 · FY2007 · CA · contact PI
Rexinoid Synergy in Prostate Cancer Apoptosis$491,162
R01 · FY2006 · CA · contact PI
Rexinoid Synergy in Prostate Cancer Apoptosis$460,204
R01 · FY2005 · CA
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY$444,098
P01 · FY2002 · CA
RETINOID DESIGN AND SYNTHESIS$256,220
P01 · FY2002 · CA
RETINOID DESIGN AND SYNTHESIS$256,220
P01 · FY2000 · CA
SELECTIVE RETINOIDS FOR BREAST CANCER THERAPY$76,185
P01 · FY2000 · CA